159 related articles for article (PubMed ID: 21427555)
81. Quality indicators of clinical cancer care (QC3) in colorectal cancer.
Bianchi V; Spitale A; Ortelli L; Mazzucchelli L; Bordoni A;
BMJ Open; 2013; 3(7):. PubMed ID: 23869102
[TBL] [Abstract][Full Text] [Related]
82. Triple negative breast cancers have a reduced expression of DNA repair genes.
Ribeiro E; Ganzinelli M; Andreis D; Bertoni R; Giardini R; Fox SB; Broggini M; Bottini A; Zanoni V; Bazzola L; Foroni C; Generali D; Damia G
PLoS One; 2013; 8(6):e66243. PubMed ID: 23825533
[TBL] [Abstract][Full Text] [Related]
83. Molecular dissection of microsatellite instable colorectal cancer.
Vilar E; Tabernero J
Cancer Discov; 2013 May; 3(5):502-11. PubMed ID: 23454900
[TBL] [Abstract][Full Text] [Related]
84. Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer.
Dienstmann R; De Dosso S; Felip E; Tabernero J
Mol Oncol; 2012 Feb; 6(1):15-26. PubMed ID: 22189054
[TBL] [Abstract][Full Text] [Related]
85. Molecular markers in the treatment of metastatic colorectal cancer.
Wilson PM; Labonte MJ; Lenz HJ
Cancer J; 2010; 16(3):262-72. PubMed ID: 20526105
[TBL] [Abstract][Full Text] [Related]
86. Predictive molecular classifiers in colorectal cancer.
Bohanes P; LaBonte MJ; Winder T; Lenz HJ
Semin Oncol; 2011 Aug; 38(4):576-87. PubMed ID: 21810517
[TBL] [Abstract][Full Text] [Related]
87. Molecular predictors of response to chemotherapy in colorectal cancer.
Dienstmann R; Vilar E; Tabernero J
Cancer J; 2011; 17(2):114-26. PubMed ID: 21427555
[TBL] [Abstract][Full Text] [Related]
88. Development of molecular biomarkers in individualized treatment of colorectal cancer.
De Mattos-Arruda L; Dienstmann R; Tabernero J
Clin Colorectal Cancer; 2011 Dec; 10(4):279-89. PubMed ID: 21729679
[TBL] [Abstract][Full Text] [Related]
89. Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.
Le Tourneau C; Vidal L; Siu LL
Drug Resist Updat; 2008 Jun; 11(3):99-109. PubMed ID: 18515176
[TBL] [Abstract][Full Text] [Related]
90. Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal cancer: beyond KRAS mutations.
Custodio A; Feliu J
Crit Rev Oncol Hematol; 2013 Jan; 85(1):45-81. PubMed ID: 22647972
[TBL] [Abstract][Full Text] [Related]
91.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
92.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
93.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
94.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
95.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
96.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
97.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
98.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
